The use of telemedicine in patients with stroke may increase the likelihood of receiving treatment but may reduce the odds of ...

The trial’s findings will dampen enthusiasm for the drug in stroke recovery, though research questions remain, one expert says.

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

BASEL, Switzerland—Multiple randomized trials presented last week at the European Stroke Organisation Conference (ESOC) 2024 have bolstered the case that tenecteplase (TNK) is an effective—if not ...

Background and ScopeMechanical thrombectomy has revolutionized the management of acute ischemic stroke (AIS), especially in ...

A new clinical trial published in the Journal of the American Medical Association revealed that adding levodopa did not ...